Zuccaro, Michael V.
LeDuc, Charles A.
Thaker, Vidhu V.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK26687)
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK26687)
Pfizer’s Centers for Therapeutic Innovation (ASPIRE Obesity Research Grant)
Article History
Accepted: 10 April 2024
First Online: 1 June 2024
Compliance with Ethical Standards
:
: Not applicable.
: VVT participates in clinical trials for genetic obesity sponsored by Rhythm Pharmaceuticals. MVZ and CAL have nothing to disclose.
: The authors declare no competing interests.
: This article does not contain any studies with human or animal subjects performed by any of the authors.